 | • レポートコード：QAF27893 • 出版社/出版日：QYResearch / 2021年4月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のソマトスタチン市場について種類別（0.25、0.75、3）、用途別（ホルモン障害、腫瘍学、代謝障害、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ソマトスタチン市場の概要 ・世界の主要地域別ソマトスタチン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のソマトスタチン市場規模2016-2021：種類別（0.25、0.75、3） ・世界のソマトスタチン市場予測2012-2027：種類別（0.25、0.75、3） ・世界のソマトスタチン市場規模2016-2021：用途別（ホルモン障害、腫瘍学、代謝障害、その他） ・世界のソマトスタチン市場予測2012-2027：用途別（ホルモン障害、腫瘍学、代謝障害、その他） ・ソマトスタチンのアメリカ市場規模と予測2016-2021 ・ソマトスタチンのヨーロッパ市場規模と予測2016-2021 ・ソマトスタチンの中国市場規模と予測2016-2021 ・ソマトスタチンの日本市場規模と予測2016-2021 ・ソマトスタチンの東南アジア市場規模と予測2016-2021 ・ソマトスタチンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Merck (Schweiz) AG、SANOFI-AVENTIS FRANCE、Lyomark Pharma GmbH、ALFA WASSERMANN S.p.A.、Polypeptide Laboratories, Inc、SAMARTH、UBPL、HYBIO、TianTaiShan、Yangtze River、Siyao、Shuangcheng、Hainan Zhonghe、SL PHARM、Wuhan Hualong、Qingdao Guoda、Chengdu Shengnuo、Longjin） ・ソマトスタチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ソマトスタチンの市場動向・機会・課題 ・調査の結論 |
Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.
Somatostatin is one of the fastest growing medical Products in recent years in China. China is also the world’s most rapid expansion Market. Rapid growth numbers of general hospital form a strong Market Demand of Somatostatin, especially the demand of second class and below second class hospital.
Market Analysis and Insights: Global Somatostatin Market
The global Somatostatin market was valued at US$ 336.6 in 2020 and will reach US$ 643.2 million by the end of 2027, growing at a CAGR of 11.4% during 2022-2027.
Global Somatostatin Scope and Market Size
The global Somatostatin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Somatostatin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
0.25
0.75
3
Segment by Application
Hormonal Disorder
Oncology
Metabolic Disorder
Others
The Somatostatin market is analysed and market size information is provided by regions (countries). Segment by Application, the Somatostatin market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Merck (Schweiz) AG
SANOFI-AVENTIS FRANCE
Lyomark Pharma GmbH
ALFA WASSERMANN S.p.A.
Polypeptide Laboratories, Inc
SAMARTH
UBPL
HYBIO
TianTaiShan
Yangtze River
Siyao
Shuangcheng
Hainan Zhonghe
SL PHARM
Wuhan Hualong
Qingdao Guoda
Chengdu Shengnuo
Longjin
1 Somatostatin Market Overview
1.1 Somatostatin Product Scope
1.2 Somatostatin Segment by Type
1.2.1 Global Somatostatin Sales by Type (2016 & 2021 & 2027)
1.2.2 0.25
1.2.3 0.75
1.2.4 3
1.3 Somatostatin Segment by Application
1.3.1 Global Somatostatin Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hormonal Disorder
1.3.3 Oncology
1.3.4 Metabolic Disorder
1.3.5 Others
1.4 Somatostatin Market Estimates and Forecasts (2016-2027)
1.4.1 Global Somatostatin Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Somatostatin Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Somatostatin Price Trends (2016-2027)
2 Somatostatin Estimates and Forecasts by Region
2.1 Global Somatostatin Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Somatostatin Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Somatostatin Sales Market Share by Region (2016-2021)
2.2.2 Global Somatostatin Revenue Market Share by Region (2016-2021)
2.3 Global Somatostatin Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Somatostatin Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Somatostatin Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Somatostatin Estimates and Projections (2016-2027)
2.4.2 Europe Somatostatin Estimates and Projections (2016-2027)
2.4.3 China Somatostatin Estimates and Projections (2016-2027)
2.4.4 Japan Somatostatin Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Somatostatin Estimates and Projections (2016-2027)
2.4.6 India Somatostatin Estimates and Projections (2016-2027)
3 Global Somatostatin Competition Landscape by Players
3.1 Global Top Somatostatin Players by Sales (2016-2021)
3.2 Global Top Somatostatin Players by Revenue (2016-2021)
3.3 Global Somatostatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Somatostatin as of 2020)
3.4 Global Somatostatin Average Price by Company (2016-2021)
3.5 Manufacturers Somatostatin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Somatostatin Market Size by Type
4.1 Global Somatostatin Historic Market Review by Type (2016-2021)
4.1.1 Global Somatostatin Sales Market Share by Type (2016-2021)
4.1.2 Global Somatostatin Revenue Market Share by Type (2016-2021)
4.1.3 Global Somatostatin Price by Type (2016-2021)
4.2 Global Somatostatin Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Somatostatin Sales Forecast by Type (2022-2027)
4.2.2 Global Somatostatin Revenue Forecast by Type (2022-2027)
4.2.3 Global Somatostatin Price Forecast by Type (2022-2027)
5 Global Somatostatin Market Size by Application
5.1 Global Somatostatin Historic Market Review by Application (2016-2021)
5.1.1 Global Somatostatin Sales Market Share by Application (2016-2021)
5.1.2 Global Somatostatin Revenue Market Share by Application (2016-2021)
5.1.3 Global Somatostatin Price by Application (2016-2021)
5.2 Global Somatostatin Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Somatostatin Sales Forecast by Application (2022-2027)
5.2.2 Global Somatostatin Revenue Forecast by Application (2022-2027)
5.2.3 Global Somatostatin Price Forecast by Application (2022-2027)
6 North America Somatostatin Market Facts & Figures
6.1 North America Somatostatin Sales by Company
6.1.1 North America Somatostatin Sales by Company (2016-2021)
6.1.2 North America Somatostatin Revenue by Company (2016-2021)
6.2 North America Somatostatin Sales Breakdown by Type
6.2.1 North America Somatostatin Sales Breakdown by Type (2016-2021)
6.2.2 North America Somatostatin Sales Breakdown by Type (2022-2027)
6.3 North America Somatostatin Sales Breakdown by Application
6.3.1 North America Somatostatin Sales Breakdown by Application (2016-2021)
6.3.2 North America Somatostatin Sales Breakdown by Application (2022-2027)
7 Europe Somatostatin Market Facts & Figures
7.1 Europe Somatostatin Sales by Company
7.1.1 Europe Somatostatin Sales by Company (2016-2021)
7.1.2 Europe Somatostatin Revenue by Company (2016-2021)
7.2 Europe Somatostatin Sales Breakdown by Type
7.2.1 Europe Somatostatin Sales Breakdown by Type (2016-2021)
7.2.2 Europe Somatostatin Sales Breakdown by Type (2022-2027)
7.3 Europe Somatostatin Sales Breakdown by Application
7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)
8 China Somatostatin Market Facts & Figures
8.1 China Somatostatin Sales by Company
8.1.1 China Somatostatin Sales by Company (2016-2021)
8.1.2 China Somatostatin Revenue by Company (2016-2021)
8.2 China Somatostatin Sales Breakdown by Type
8.2.1 China Somatostatin Sales Breakdown by Type (2016-2021)
8.2.2 China Somatostatin Sales Breakdown by Type (2022-2027)
8.3 China Somatostatin Sales Breakdown by Application
8.3.1 China 313 Sales Breakdown by Application (2016-2021)
8.3.2 China 313 Sales Breakdown by Application (2022-2027)
9 Japan Somatostatin Market Facts & Figures
9.1 Japan Somatostatin Sales by Company
9.1.1 Japan Somatostatin Sales by Company (2016-2021)
9.1.2 Japan Somatostatin Revenue by Company (2016-2021)
9.2 Japan Somatostatin Sales Breakdown by Type
9.2.1 Japan Somatostatin Sales Breakdown by Type (2016-2021)
9.2.2 Japan Somatostatin Sales Breakdown by Type (2022-2027)
9.3 Japan Somatostatin Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Somatostatin Market Facts & Figures
10.1 Southeast Asia Somatostatin Sales by Company
10.1.1 Southeast Asia Somatostatin Sales by Company (2016-2021)
10.1.2 Southeast Asia Somatostatin Revenue by Company (2016-2021)
10.2 Southeast Asia Somatostatin Sales Breakdown by Type
10.2.1 Southeast Asia Somatostatin Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Somatostatin Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Somatostatin Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)
11 India Somatostatin Market Facts & Figures
11.1 India Somatostatin Sales by Company
11.1.1 India Somatostatin Sales by Company (2016-2021)
11.1.2 India Somatostatin Revenue by Company (2016-2021)
11.2 India Somatostatin Sales Breakdown by Type
11.2.1 India Somatostatin Sales Breakdown by Type (2016-2021)
11.2.2 India Somatostatin Sales Breakdown by Type (2022-2027)
11.3 India Somatostatin Sales Breakdown by Application
11.3.1 India Somatostatin Sales Breakdown by Application (2016-2021)
11.3.2 India Somatostatin Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Somatostatin Business
12.1 Merck (Schweiz) AG
12.1.1 Merck (Schweiz) AG Corporation Information
12.1.2 Merck (Schweiz) AG Business Overview
12.1.3 Merck (Schweiz) AG Somatostatin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck (Schweiz) AG Somatostatin Products Offered
12.1.5 Merck (Schweiz) AG Recent Development
12.2 SANOFI-AVENTIS FRANCE
12.2.1 SANOFI-AVENTIS FRANCE Corporation Information
12.2.2 SANOFI-AVENTIS FRANCE Business Overview
12.2.3 SANOFI-AVENTIS FRANCE Somatostatin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 SANOFI-AVENTIS FRANCE Somatostatin Products Offered
12.2.5 SANOFI-AVENTIS FRANCE Recent Development
12.3 Lyomark Pharma GmbH
12.3.1 Lyomark Pharma GmbH Corporation Information
12.3.2 Lyomark Pharma GmbH Business Overview
12.3.3 Lyomark Pharma GmbH Somatostatin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Lyomark Pharma GmbH Somatostatin Products Offered
12.3.5 Lyomark Pharma GmbH Recent Development
12.4 ALFA WASSERMANN S.p.A.
12.4.1 ALFA WASSERMANN S.p.A. Corporation Information
12.4.2 ALFA WASSERMANN S.p.A. Business Overview
12.4.3 ALFA WASSERMANN S.p.A. Somatostatin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 ALFA WASSERMANN S.p.A. Somatostatin Products Offered
12.4.5 ALFA WASSERMANN S.p.A. Recent Development
12.5 Polypeptide Laboratories, Inc
12.5.1 Polypeptide Laboratories, Inc Corporation Information
12.5.2 Polypeptide Laboratories, Inc Business Overview
12.5.3 Polypeptide Laboratories, Inc Somatostatin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Polypeptide Laboratories, Inc Somatostatin Products Offered
12.5.5 Polypeptide Laboratories, Inc Recent Development
12.6 SAMARTH
12.6.1 SAMARTH Corporation Information
12.6.2 SAMARTH Business Overview
12.6.3 SAMARTH Somatostatin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 SAMARTH Somatostatin Products Offered
12.6.5 SAMARTH Recent Development
12.7 UBPL
12.7.1 UBPL Corporation Information
12.7.2 UBPL Business Overview
12.7.3 UBPL Somatostatin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 UBPL Somatostatin Products Offered
12.7.5 UBPL Recent Development
12.8 HYBIO
12.8.1 HYBIO Corporation Information
12.8.2 HYBIO Business Overview
12.8.3 HYBIO Somatostatin Sales, Revenue and Gross Margin (2016-2021)
12.8.4 HYBIO Somatostatin Products Offered
12.8.5 HYBIO Recent Development
12.9 TianTaiShan
12.9.1 TianTaiShan Corporation Information
12.9.2 TianTaiShan Business Overview
12.9.3 TianTaiShan Somatostatin Sales, Revenue and Gross Margin (2016-2021)
12.9.4 TianTaiShan Somatostatin Products Offered
12.9.5 TianTaiShan Recent Development
12.10 Yangtze River
12.10.1 Yangtze River Corporation Information
12.10.2 Yangtze River Business Overview
12.10.3 Yangtze River Somatostatin Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Yangtze River Somatostatin Products Offered
12.10.5 Yangtze River Recent Development
12.11 Siyao
12.11.1 Siyao Corporation Information
12.11.2 Siyao Business Overview
12.11.3 Siyao Somatostatin Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Siyao Somatostatin Products Offered
12.11.5 Siyao Recent Development
12.12 Shuangcheng
12.12.1 Shuangcheng Corporation Information
12.12.2 Shuangcheng Business Overview
12.12.3 Shuangcheng Somatostatin Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Shuangcheng Somatostatin Products Offered
12.12.5 Shuangcheng Recent Development
12.13 Hainan Zhonghe
12.13.1 Hainan Zhonghe Corporation Information
12.13.2 Hainan Zhonghe Business Overview
12.13.3 Hainan Zhonghe Somatostatin Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Hainan Zhonghe Somatostatin Products Offered
12.13.5 Hainan Zhonghe Recent Development
12.14 SL PHARM
12.14.1 SL PHARM Corporation Information
12.14.2 SL PHARM Business Overview
12.14.3 SL PHARM Somatostatin Sales, Revenue and Gross Margin (2016-2021)
12.14.4 SL PHARM Somatostatin Products Offered
12.14.5 SL PHARM Recent Development
12.15 Wuhan Hualong
12.15.1 Wuhan Hualong Corporation Information
12.15.2 Wuhan Hualong Business Overview
12.15.3 Wuhan Hualong Somatostatin Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Wuhan Hualong Somatostatin Products Offered
12.15.5 Wuhan Hualong Recent Development
12.16 Qingdao Guoda
12.16.1 Qingdao Guoda Corporation Information
12.16.2 Qingdao Guoda Business Overview
12.16.3 Qingdao Guoda Somatostatin Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Qingdao Guoda Somatostatin Products Offered
12.16.5 Qingdao Guoda Recent Development
12.17 Chengdu Shengnuo
12.17.1 Chengdu Shengnuo Corporation Information
12.17.2 Chengdu Shengnuo Business Overview
12.17.3 Chengdu Shengnuo Somatostatin Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Chengdu Shengnuo Somatostatin Products Offered
12.17.5 Chengdu Shengnuo Recent Development
12.18 Longjin
12.18.1 Longjin Corporation Information
12.18.2 Longjin Business Overview
12.18.3 Longjin Somatostatin Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Longjin Somatostatin Products Offered
12.18.5 Longjin Recent Development
13 Somatostatin Manufacturing Cost Analysis
13.1 Somatostatin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Somatostatin
13.4 Somatostatin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Somatostatin Distributors List
14.3 Somatostatin Customers
15 Market Dynamics
15.1 Somatostatin Market Trends
15.2 Somatostatin Drivers
15.3 Somatostatin Market Challenges
15.4 Somatostatin Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Somatostatin Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Somatostatin Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Somatostatin Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Somatostatin Sales (K Pcs) by Region (2016-2021)
Table 5. Global Somatostatin Sales Market Share by Region (2016-2021)
Table 6. Global Somatostatin Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Somatostatin Revenue Share by Region (2016-2021)
Table 8. Global Somatostatin Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Somatostatin Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Somatostatin Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Somatostatin Revenue Share Forecast by Region (2022-2027)
Table 12. Global Somatostatin Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Somatostatin Sales Share by Company (2016-2021)
Table 14. Global Somatostatin Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Somatostatin Revenue Share by Company (2016-2021)
Table 16. Global Somatostatin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Somatostatin as of 2020)
Table 17. Global Somatostatin Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Somatostatin Manufacturing Sites and Area Served
Table 19. Manufacturers Somatostatin Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Somatostatin Sales (K Pcs) by Type (2016-2021)
Table 22. Global Somatostatin Sales Share by Type (2016-2021)
Table 23. Global Somatostatin Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Somatostatin Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Somatostatin Sales Share by Type (2022-2027)
Table 26. Global Somatostatin Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Somatostatin Revenue Share by Type (2022-2027)
Table 28. Global Somatostatin Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Somatostatin Sales (K Pcs) by Application (2016-2021)
Table 30. Global Somatostatin Sales Share by Application (2016-2021)
Table 31. Global Somatostatin Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Somatostatin Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Somatostatin Sales (K Pcs) by Application (2022-2027)
Table 34. Global Somatostatin Sales Share by Application (2022-2027)
Table 35. Global Somatostatin Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Somatostatin Revenue Share by Application (2022-2027)
Table 37. Global Somatostatin Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Somatostatin Sales (K Pcs) by Company (2016-2021)
Table 39. North America Somatostatin Sales Market Share by Company (2016-2021)
Table 40. North America Somatostatin Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Somatostatin Revenue Market Share by Company (2016-2021)
Table 42. North America Somatostatin Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Somatostatin Sales Market Share by Type (2016-2021)
Table 44. North America Somatostatin Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Somatostatin Sales Market Share by Type (2022-2027)
Table 46. North America Somatostatin Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Somatostatin Sales Market Share by Application (2016-2021)
Table 48. North America Somatostatin Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Somatostatin Sales Market Share by Application (2022-2027)
Table 50. Europe Somatostatin Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Somatostatin Sales Market Share by Company (2016-2021)
Table 52. Europe Somatostatin Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Somatostatin Revenue Market Share by Company (2016-2021)
Table 54. Europe Somatostatin Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Somatostatin Sales Market Share by Type (2016-2021)
Table 56. Europe Somatostatin Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Somatostatin Sales Market Share by Type (2022-2027)
Table 58. Europe Somatostatin Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Somatostatin Sales Market Share by Application (2016-2021)
Table 60. Europe Somatostatin Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Somatostatin Sales Market Share by Application (2022-2027)
Table 62. China Somatostatin Sales (K Pcs) by Company (2016-2021)
Table 63. China Somatostatin Sales Market Share by Company (2016-2021)
Table 64. China Somatostatin Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Somatostatin Revenue Market Share by Company (2016-2021)
Table 66. China Somatostatin Sales by Type (2016-2021) & (K Pcs)
Table 67. China Somatostatin Sales Market Share by Type (2016-2021)
Table 68. China Somatostatin Sales by Type (2022-2027) & (K Pcs)
Table 69. China Somatostatin Sales Market Share by Type (2022-2027)
Table 70. China Somatostatin Sales by Application (2016-2021) & (K Pcs)
Table 71. China Somatostatin Sales Market Share by Application (2016-2021)
Table 72. China Somatostatin Sales by Application (2022-2027) & (K Pcs)
Table 73. China Somatostatin Sales Market Share by Application (2022-2027)
Table 74. Japan Somatostatin Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Somatostatin Sales Market Share by Company (2016-2021)
Table 76. Japan Somatostatin Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Somatostatin Revenue Market Share by Company (2016-2021)
Table 78. Japan Somatostatin Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Somatostatin Sales Market Share by Type (2016-2021)
Table 80. Japan Somatostatin Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Somatostatin Sales Market Share by Type (2022-2027)
Table 82. Japan Somatostatin Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Somatostatin Sales Market Share by Application (2016-2021)
Table 84. Japan Somatostatin Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Somatostatin Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Somatostatin Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Somatostatin Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Somatostatin Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Somatostatin Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Somatostatin Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Somatostatin Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Somatostatin Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Somatostatin Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Somatostatin Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Somatostatin Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Somatostatin Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Somatostatin Sales Market Share by Application (2022-2027)
Table 98. India Somatostatin Sales (K Pcs) by Company (2016-2021)
Table 99. India Somatostatin Sales Market Share by Company (2016-2021)
Table 100. India Somatostatin Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Somatostatin Revenue Market Share by Company (2016-2021)
Table 102. India Somatostatin Sales by Type (2016-2021) & (K Pcs)
Table 103. India Somatostatin Sales Market Share by Type (2016-2021)
Table 104. India Somatostatin Sales by Type (2022-2027) & (K Pcs)
Table 105. India Somatostatin Sales Market Share by Type (2022-2027)
Table 106. India Somatostatin Sales by Application (2016-2021) & (K Pcs)
Table 107. India Somatostatin Sales Market Share by Application (2016-2021)
Table 108. India Somatostatin Sales by Application (2022-2027) & (K Pcs)
Table 109. India Somatostatin Sales Market Share by Application (2022-2027)
Table 110. Merck (Schweiz) AG Corporation Information
Table 111. Merck (Schweiz) AG Description and Business Overview
Table 112. Merck (Schweiz) AG Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Merck (Schweiz) AG Somatostatin Product
Table 114. Merck (Schweiz) AG Recent Development
Table 115. SANOFI-AVENTIS FRANCE Corporation Information
Table 116. SANOFI-AVENTIS FRANCE Description and Business Overview
Table 117. SANOFI-AVENTIS FRANCE Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. SANOFI-AVENTIS FRANCE Somatostatin Product
Table 119. SANOFI-AVENTIS FRANCE Recent Development
Table 120. Lyomark Pharma GmbH Corporation Information
Table 121. Lyomark Pharma GmbH Description and Business Overview
Table 122. Lyomark Pharma GmbH Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Lyomark Pharma GmbH Somatostatin Product
Table 124. Lyomark Pharma GmbH Recent Development
Table 125. ALFA WASSERMANN S.p.A. Corporation Information
Table 126. ALFA WASSERMANN S.p.A. Description and Business Overview
Table 127. ALFA WASSERMANN S.p.A. Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. ALFA WASSERMANN S.p.A. Somatostatin Product
Table 129. ALFA WASSERMANN S.p.A. Recent Development
Table 130. Polypeptide Laboratories, Inc Corporation Information
Table 131. Polypeptide Laboratories, Inc Description and Business Overview
Table 132. Polypeptide Laboratories, Inc Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Polypeptide Laboratories, Inc Somatostatin Product
Table 134. Polypeptide Laboratories, Inc Recent Development
Table 135. SAMARTH Corporation Information
Table 136. SAMARTH Description and Business Overview
Table 137. SAMARTH Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. SAMARTH Somatostatin Product
Table 139. SAMARTH Recent Development
Table 140. UBPL Corporation Information
Table 141. UBPL Description and Business Overview
Table 142. UBPL Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. UBPL Somatostatin Product
Table 144. UBPL Recent Development
Table 145. HYBIO Corporation Information
Table 146. HYBIO Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. HYBIO Description and Business Overview
Table 148. HYBIO Somatostatin Product
Table 149. HYBIO Recent Development
Table 150. TianTaiShan Corporation Information
Table 151. TianTaiShan Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. TianTaiShan Description and Business Overview
Table 153. TianTaiShan Somatostatin Product
Table 154. TianTaiShan Recent Development
Table 155. Yangtze River Corporation Information
Table 156. Yangtze River Description and Business Overview
Table 157. Yangtze River Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Yangtze River Somatostatin Product
Table 159. Yangtze River Recent Development
Table 160. Siyao Corporation Information
Table 161. Siyao Description and Business Overview
Table 162. Siyao Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. Siyao Somatostatin Product
Table 164. Siyao Recent Development
Table 165. Shuangcheng Corporation Information
Table 166. Shuangcheng Description and Business Overview
Table 167. Shuangcheng Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Shuangcheng Somatostatin Product
Table 169. Shuangcheng Recent Development
Table 170. Hainan Zhonghe Corporation Information
Table 171. Hainan Zhonghe Description and Business Overview
Table 172. Hainan Zhonghe Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. Hainan Zhonghe Somatostatin Product
Table 174. Hainan Zhonghe Recent Development
Table 175. SL PHARM Corporation Information
Table 176. SL PHARM Description and Business Overview
Table 177. SL PHARM Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 178. SL PHARM Somatostatin Product
Table 179. SL PHARM Recent Development
Table 180. Wuhan Hualong Corporation Information
Table 181. Wuhan Hualong Description and Business Overview
Table 182. Wuhan Hualong Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 183. Wuhan Hualong Somatostatin Product
Table 184. Wuhan Hualong Recent Development
Table 185. Qingdao Guoda Corporation Information
Table 186. Qingdao Guoda Description and Business Overview
Table 187. Qingdao Guoda Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 188. Qingdao Guoda Somatostatin Product
Table 189. Qingdao Guoda Recent Development
Table 190. Chengdu Shengnuo Corporation Information
Table 191. Chengdu Shengnuo Description and Business Overview
Table 192. Chengdu Shengnuo Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 193. Chengdu Shengnuo Somatostatin Product
Table 194. Chengdu Shengnuo Recent Development
Table 195. Longjin Corporation Information
Table 196. Longjin Description and Business Overview
Table 197. Longjin Somatostatin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 198. Longjin Somatostatin Product
Table 199. Longjin Recent Development
Table 200. Production Base and Market Concentration Rate of Raw Material
Table 201. Key Suppliers of Raw Materials
Table 202. Somatostatin Distributors List
Table 203. Somatostatin Customers List
Table 204. Somatostatin Market Trends
Table 205. Somatostatin Market Drivers
Table 206. Somatostatin Market Challenges
Table 207. Somatostatin Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Somatostatin Product Picture
Figure 2. Global Somatostatin Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Somatostatin Sales Market Share by Application in 2021 & 2027
Figure 6. Hormonal Disorder Examples
Figure 7. Oncology Examples
Figure 8. Metabolic Disorder Examples
Figure 9. Others Examples
Figure 10. Global Somatostatin Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Somatostatin Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Somatostatin Sales (K Pcs) Growth Rate (2016-2027)
Figure 13. Global Somatostatin Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 14. Global Somatostatin Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Somatostatin Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Somatostatin Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Somatostatin Sales (K Pcs) Growth Rate (2016-2027)
Figure 18. Europe Somatostatin Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Somatostatin Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Somatostatin Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Somatostatin Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Somatostatin Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Somatostatin Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Somatostatin Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Somatostatin Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Somatostatin Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Somatostatin Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Somatostatin Players Market Share by Revenue in Somatostatin: 2016 & 2020
Figure 29. Somatostatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Somatostatin Revenue Share by Type (2016-2021)
Figure 31. Global Somatostatin Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Somatostatin Revenue Share by Application (2016-2021)
Figure 33. Global Somatostatin Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Somatostatin Sales Market Share by Type in 2020
Figure 35. North America Somatostatin Sales Market Share by Application in 2020
Figure 36. Europe Somatostatin Sales Market Share by Type in 2020
Figure 37. Europe Somatostatin Sales Market Share by Application in 2020
Figure 38. China Somatostatin Sales Market Share by Type in 2020
Figure 39. China Somatostatin Sales Market Share by Application in 2020
Figure 40. Japan Somatostatin Sales Market Share by Type in 2020
Figure 41. Japan Somatostatin Sales Market Share by Application in 2020
Figure 42. Southeast Asia Somatostatin Sales Market Share by Type in 2020
Figure 43. Southeast Asia Somatostatin Sales Market Share by Application in 2020
Figure 44. India Somatostatin Sales Market Share by Type in 2020
Figure 45. India Somatostatin Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Somatostatin
Figure 48. Manufacturing Process Analysis of Somatostatin
Figure 49. Somatostatin Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
世界のソマトスタチン受容体2型市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Somatostatin Receptor Type 2 Market The global Somatostatin Receptor Type 2 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…- ソマトスタチンのグローバル市場2021 Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and g…
- 世界の代謝性疾患治療薬市場規模・現状・予測（2021年-2027年） Increasing demand for one-time therapies for metabolic disorders and rising prevalence of lifestyle diseases are the key factors that are expected to boost the growth of this market. Market Analysis and Insights: Global Metabolic Disorder Therapeutics Market The global Metabolic Disorder Therapeutic…
- 世界のHPV関連疾患市場規模・現状・予測（2021年-2027年） HPV Associated Disorder means a series of diseases associated with HPV, either pre-disease or some of the diseases induced thereby. Market Analysis and Insights: Global HPV Associated Disorder Market The global HPV Associated Disorder market size is projected to reach US$ XX million by 2027, from US…
- 世界の甲状腺障害市場規模・現状・予測（2021年-2027年） Thyroid disorders may lead to elevated or decreased levels of metabolic hormones, leading to medical conditions such as hypothyroidism, hyperthyroidism, etc. falling under the category of thyroid disorders. The global thyroid disorder market is estimated to be driven by the increasing prevalence of …